Loomis, Sayles & Company
DH icon

Loomis, Sayles & Company’s Definitive Healthcare DH Stock Holding History

Loomis, Sayles & Company’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-650
Closed -$7K – 996
2023
Q1 		$7K Buy
650
+493
+314% +$5.8K ﹤0.01% 889
2022
Q4 		$2K Buy
157
+78
+99% +$1K ﹤0.01% 817
2022
Q3 		$1K Hold
79
– – ﹤0.01% 889
2022
Q2 		$2K Buy
+79
New +$1.69K ﹤0.01% 824

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Loomis, Sayles & Company's DH Position: Q2 2023 in Review

Loomis, Sayles & Company sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 650 shares — an estimated $7K sold.

Loomis, Sayles & Company first reported a position in DH in Q2 2022 and held it in 4 quarters. The position peaked at $7K in Q1 2023. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

  • Loomis, Sayles & Company reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 650 Definitive Healthcare shares in Q2 2023, an estimated $7K.
  • Loomis, Sayles & Company first reported a position in Definitive Healthcare in Q2 2022 and held it in 4 quarters.
  • Loomis, Sayles & Company's Definitive Healthcare position peaked at $7K in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.